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NusA is an essential protein that binds to RNA polymerase
and also to the nascent RNA and influences transcription by
inducing pausing and facilitating the process of transcription
termination/antitermination. Its participation in Rho-depen-
dent transcription termination has been perceived, but the
molecular nature of this involvement is not known.We hypoth-
esized that, because both Rho and NusA are RNA-binding pro-
teins and have the potential to target the same RNA, the latter is
likely to influence the global pattern of the Rho-dependent ter-
mination. Analyses of the nascent RNA binding properties and
consequent effects on the Rho-dependent termination func-
tions of specific NusA-RNA binding domain mutants revealed
an existence of Rho-NusA direct competition for the overlap-
ping nut (NusA-binding site) and rut (Rho-binding site) sites on
the RNA. This leads to delayed entry of Rho at the rut site that
inhibits the latter’s RNA release process. High density tiling
microarray profiles of these NusA mutants revealed that a sig-
nificant number of genes, together with transcripts from inter-
genic regions, are up-regulated. Interestingly, the majority of
these genes were also up-regulated when the Rho function was
compromised. These results provide strong evidence for the
existence of NusA-binding sites in different operons that are
also the targets of Rho-dependent terminations. Our data
strongly argue in favor of a direct competition between NusA
andRho for the access of specific sites on the nascent transcripts
in different parts of the genome.We propose that this competi-
tion enables NusA to function as a global antagonist of the Rho
function, which is unlike its role as a facilitator of hairpin-de-
pendent termination.
The bacterial transcription terminator, Rho, functions as a
hexameric RNA-dependent ATPase that is capable of translo-
cating along the RNA. It dislodges the elongating RNA poly-
merase (RNAP)4 once it is loaded onto the nascent RNA (1, 2).
Its termination function is facilitated upon interaction with the
transcription elongation factor, NusG (3–5). Recent genomics
studies have revealed that Rho-dependent termination occurs
at more than one-third of the operons of a dividing Escherichia
coli (6, 7). Thismode of transcription termination is involved in
many physiological processes, like control of translation (2),
riboswitch formation (8), inhibition of unwanted antisense
transcription, etc. (7). Rho is capable of loading onto unstruc-
tured stretches of RNA (the rut ([R]ho [ut]ilization) sites), and
once it is bound to the RNA, it translocates in a processive
manner along the 5to 3 direction, which may induce
unwanted termination of transcription. Interestingly, in vivo
negative regulation by cellular factors or any control switch of
the Rho function has not been documented. In principle, any
RNA-binding protein that has overlapping binding sites with
the rut sites on the nascent RNA could influence the Rho activ-
ity by a direct competition for occupancy of the same sites.
NusA, a ubiquitous transcription elongation factor of bacte-
ria, interacts with nascent RNA upon binding to the elongating
RNAP (9). The NusA N-terminal domain interacts with the
-flap domain of the RNAP, whereas its S1-KH1-KH2 (SKK)
domain interacts with the nascent RNA (Fig. 1A). The AR1 and
AR2 domains interact with the antiterminator protein N and
the -subunit of RNAP, respectively (9). Nut (N utilization)
sites of lambdoid phages and the sequences in the antitermina-
tion box (AT-box) found in the rRNAoperons are the few char-
acterized high affinity NusA binding sites on the RNAs (10)
(Fig. 1B). On the AT-box, NusA together withNusB, NusE, and
other ribosomal proteins forman antitermination complex that
increases the rate of transcription elongation in the rrn oper-
ons, which is believed to decrease the kinetic window for the
Rho protein to act (11). In general, NusA induces pauses during
the transcription elongation. In particular, the hairpin-depen-
dent pauses are enhanced by NusA via stabilization of the hair-
pin-RNAP interaction (12). NusA improves the termination
efficiency at many hairpin-dependent terminators by facilitat-
ing the hairpin folding (13) and also by stabilizing the latter’s
interactions in the RNA exit channel of the transcription elon-
gation complex (14).
Previously, different studies have indicated the involvement
of NusA in the Rho-dependent termination process (15–17). A
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NusA mutant, nusA1, was shown to suppress defects of a Rho
mutant (16). In in vitro Rho-dependent termination assays, the
presence of NusA delayed the Rho-dependent termination
(18). Genome-wide gene expression patterns of NusA-deleted
strains showed same pattern as that of the NusG-deleted ones,
where the latter is a bona fide partner of Rho (6).More recently,
aNusAmutantwas observed to produce a termination defect at
a Rho-dependent terminator, H-19B tR1 (17).
NusA, by virtue of its RNA and RNAP binding properties,
could affect Rho-dependent terminations in differentways (Fig.
1A). NusA and Rho may compete for the same or overlapping
binding sites on the exiting mRNA; thereby, the former could
act as an antagonist to the latter (Fig. 1C describes this case).
NusA-induced pausing of the transcription elongation com-
plex (EC)may facilitate the Rho-dependent termination.More-
over, NusAmay alsomodulate the access of the EC exit channel
to Rho by interacting with the exit channel-forming domain,
the -subunit flap.
Here, we isolated and characterized two NusA mutants,
located in the SKKdomain, that exhibited inhibition of Rho-de-
pendent termination strictly in a nut site-dependent manner.
Higher affinity of these mutants for the nut site helps them to
compete with the RNA loading step(s) of Rho. A genome-wide
gene expression pattern revealed that a significant number of
genes/operons were up-regulated when these two NusA
mutants were expressed. Gene expressions of the majority of
these up-regulated operons were also under the control of Rho-
dependent termination. This indicated that NusA-induced
inhibition of the Rho-dependent termination is widespread
throughout the genome.We propose that NusA, contrary to its
role as a facilitator of hairpin-dependent termination, functions
as a general antagonist of Rho-dependent termination, which
helps bacteria to avoid unwanted transcription termination of
the latter kind.
Experimental Procedures
Materials—NTPs for in vitro transcription reactions were
from GE Healthcare. [-32P]ATP (3000 Ci/mmol) and
[-32P]CTP (3000 Ci/mmol) were from Jonaki, Board of Radi-
ation and Isotope Technology (Hyderabad, India). Antibiotics,
isopropyl 1-thio--D-galactopyranoside, lysozyme, DTT, and
BSA were purchased from Affymetrix. Primers for PCR were
obtained from either MWG or Xcelri. Restriction endonu-
cleases, polynucleotide kinase, and T4 DNA ligase were
obtained fromNew England Biolabs.WT E. coli RNAP holoen-
zyme was purchased from Epicenter Biotechnologies. Taq
DNA polymerases were either from Roche Applied Science or
from Sigma or Invitrogen. Nickel-nitrilotriacetic acid-agarose
beads were from Qiagen. Streptavidin-coated magnetic beads
were from Promega. The bacterial RNA purification kit was
from Qiagen. RNAlaterTM used for storing RNA samples used
in microarray experiments was from Ambion. All of the bacte-
rial growth media were from Difco.
Isolation of NusA Mutants—The nusAmutants defective for
rho-dependent termination were isolated from the E. coli
MC4100 strain (RS734) having a single terminator (tR1) con-
taining reporter cassette Plac-H19B tR1-lacZYA, residing as a
RS45 lysogen. A random mutagenized library of the nusA
cloned in a low copy (5) pCL1920 plasmid (pRS1472) was
prepared by passing it through the XL-1 Red mutator strain
(Stratagene) (19). The mutagenized library obtained from the
mutator strain was then electroporated into RS734, following
which the genomic copy of the nusAwas deleted by P1 (nusA:
KanR) transduction, and the transductants were screened for
pink colonies onMacConkey-lactose plates. The plasmids from
pink colonies were isolated, retransformed to confirm the phe-
notype, and sequenced to identify the mutations. All of the
strains used are listed in Table 1.
In Vivo Termination Assays—The in vivo termination assays
were performed in E. coli MC4100 rac strain. Strains having
the reporters Plac-H19BtR1-lacZYA (RS734), Plac-tR1-lacZYA
(RS1019), Plac-trpt-lacZYA (RS1038), and PRM-trac-lacZYA
(RS1428) were used to measure the -galactosidase activities,
which in turn gave the in vivo termination efficiency at the
terminators present upstream of the lacZ gene. These strains
were transformed with pCL1920 plasmids expressing WT
(pRS1472), G181D (pRS1252), and R258C (pRS1251) NusA
proteins. The genomic copy of the nusA of these strains was
deleted by P1 (nusA:KanR) transduction.
To study whether overexpression of different varieties of
either full-length NusA or its RNA-binding domain (SKK)
alone is capable of producing the Rho inhibition effect, we
expressed them from a modified pBAD vector, pHYD3011, in
the presence of chromosomal nusA. The strains RS734 and
RS1428 were transformed with the pHYD3011 plasmids
expressing WT NusA (pRS703) and its mutant derivatives,
G181D (pRS1522) and R258C (pRS1165). Similarly, different
SKK fragments havingWTorG181DorR258Cmutationswere
also expressed from the plasmids pRS1396, pRS1520, and
pRS1521, respectively. The strains were cultured overnight in
the presence of 0.1% glucose to suppress the nusA expressions
from these plasmids, which was followed by subculturing them
in the absence of glucose to express the genes, and subsequently
the Rho-dependent termination efficiencies were measured as
described above.
All of the measurements of -galactosidase activities were
performed at 37 °C using a SpectramaxTM Plus plate reader
following the published procedures (20).
Preparations of Different NusA Mutants and Fragments—
The NusA mutants, R258C and G181D, were constructed in
pCL1920 by site-directed mutagenesis (Stratagene). These
mutant derivatives and the SKK fragments of NusA were also
cloned in the pHYD3011 plasmid to be used in in vivo compe-
tition assays. For in vitro experiments, full-length and SKK frag-
ment of R258CNusA were made in a pET28b plasmid to intro-
duce a C-terminal His tag, whereas to introduce a heart muscle
kinase tag in the N terminus, these mutants were also cloned in
pET33b plasmid. This tag was used for end-labeling with 32P.
To check the in vivo levels of NusA by Western blotting, His-
tagged derivatives of the SKK fragment having WT, G181D,
and R258C sequences were also cloned in pHYD3011 plasmids;
these constructs have an N-terminal hexahistidine tag. Purifi-
cation of these NusA derivatives was performed using nickel-
nitrilotriacetic acid beads (Qiagen). Labeling of the heart mus-
cle kinase-tagged R258C NusA was performed using protein
kinase A and [-32P]ATP (3000 Ci/mmol).
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DNA Template Preparations—Linear DNA templates for in
vitro transcription assays weremade by PCRusing the plasmids
pRS604 (T7A1-tR1; oligonucleotide pairs RS83/RS147, RS83/
RS333, and RS83/994), pRS106 (pT7A1-trpt; oligonucleotide
pairs RS83/RSRK-1, RS83/RS303, and RS83/177), pRS649 (rho
gene with its own promoter; oligonucleotide pairs RS323/
RS555 and RS1116/RS1142), and pRS1609 (pT7A1-AT-trpt-
lacZ; oligonucleotide pairs RS83/RSRK-1). These DNA frag-
ments were gel-purified. When required, a lac operator
sequence was inserted after the terminator regions using a
downstream primer having the operator sequence. In order
to immobilize the DNA templates to the streptavidin-coated
magnetic beads, a biotin group at the 5-end of the templates
was incorporated by using the biotinylated primer RS83. In
all of these templates, transcription was initiated from a
T7A1 promoter unless mentioned otherwise. All of the
plasmids used to make the DNA templates are listed in
Table 1.
In Vitro Termination Assays—For the transcription using
strong T7A1 promoter, we followed the regime of single round
transcription. However, due to the poor yield from Prho pro-
moter,multiple-round transcriptionwas employed by omitting
rifampicin from the reaction mixture. Reactions were carried
out in the transcription buffer (20 mM Tris-Cl, pH 8.0, 10 mM
MgCl, 50mMKCl, 1mMDTT, and 100g/ml BSA) at 37 °C. For
single round transcription, the reactionswere initiatedwith 175
M ApU, 5 M GTP, 5 M ATP, 2.5 M CTP, and [-32P]CTP
(3000 Ci/mmol) to make a 23-mer EC (EC23). The EC23 was
then chasedwith 250Meach ofATP,GTP,CTP, andUTP. For
multiple-round transcription, the RNAP-promoter complex
was chased with 250 M each of ATP, GTP, and UTP. In these
reactions, concentrations of DNA template, RNAP, NusA, and
Rhowere 5, 25, 200, and 50 nM, respectively. The concentration
of CTP was 50 M, and the RNA was labeled with [-32P]CTP
(3000Ci/mmol). The reactionswere stopped by extractionwith
phenol followed by ethanol precipitation. Samples were loaded
onto a 6% sequencing gel and analyzed using an FLA9000 phos-
phor imager (Fuji).
RNARelease Kinetics—Formeasuring the RNA release kinet-
ics from the stalled ECs, transcription reactions were per-
formed in the presence of 100 nM lac repressor so that the ECs
are roadblocked at the lacO site present downstream of the
terminator region. The DNA templates were immobilized on
streptavidin magnetic beads (Promega) through streptavidin-
biotin interaction. The transcription reactions were continued
for 2 min to form the stalled EC, and the excess NTPs were
removed by thoroughly washing the beads, following which 50
nM Rho plus 1 mM ATP was added. 10 l of samples were
removed at different time points and separated into superna-
tant (S) and pellet (P) fractions by keeping the microcentrifuge
tubes on magnetic stands. Half of the supernatant (S) was
directly mixed with an equal volume of formaldehyde loading
buffer. The rest of the sample (S P) was phenol-extracted and
mixed with dye. Fractions of released RNA ((2S)/(S) (S P))
were plotted against time, and the curves were fitted to expo-
nential rise equations either of the form, y a(1 expbx) or
y y0 a(1 expbx), where b denotes the rate, a ismaximum
RNA release amount, and y0 is the residual amount of RNA
release at the 0 time point.
TABLE 1
Strains, plasmids, and phages
Description Source/Reference
Strains
GJ3161 MC4100 galEp3 Ref. 49
MG1655
GJ5147 (RS734) MC4100 galEp3, Plac H-19B nutR-tR1- lacZYA J. Gowrishankar
RS1019 MC4100 galEp3, RS45 lysogen carrying Plac-nutR-tR1lacZYA Ref. 22
RS1038 MC4100 galEp3, RS45 lysogen carrying Plac- trpt-lacZYA Ref. 22
RS1428 MC4100 galEp3, RS45 lysogen carrying PRMracR/tRAC- lacZYA Ref. 21
RS1471 MC4100 galEp3, RS45 lysogen carrying PLacAT-H19B nutR-tR1- lacZYA
XL1-Red endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac mutD5 mutS mutT Tn10 (TetR) Stratagene
Phage
RS45 J. Gowrishankar
Plasmids
pHyd3011
pRS22 pTL61 T with pT7A1-H-19B nutR-TRT1T2-lacZYA, AmpR Ref. 50
pRS106 pT7A1-trp t-lacZ, AmpR Ref. 43
pRS431 pTL61T with Plac lacZYA by deletion of H-19B nutR-tR1 between HindIII and BamHI sites from pK8628, AmpR Ref. 20
pRS604 T7A1-TR1 fragment cloned at HindIII site of pRS22. Ref. 41
pRS649 pCL1920 with rho (WT) with its own promoter cloned at HindIII and SacI sites. Ref. 22
pRS703 nusA (WT-FL) cloned at NdeI/SalI sites of pHYD3011 vector, AmpR Ref. 25
pRS1165 nusA (R258C-FL) cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1251 nusA (R258C) with nusA promoter cloned at BamHI/SalI sites of pCL1920 vector, SpecR, StrepR This study
pRS1252 nusA (G181D) with nusA promoter cloned at BamHI/SalI sites of pCL1920 vector, SpecR, StrepR This study
pRS1396 nusA (WT-SKK) cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1447 pTL61T with PLac- rrnG AT-H-19B nutR-tR1 -lac ZYA, AmpR This study
pRS1472 nusA (WT) with nusA promoter cloned at BamHI/SalI sites of pCL1920 vector, SpecR, StrepR This study
pRS1520 nusA (G181D-SKK) cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1521 nusA (R258C-SKK) cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1522 nusA (G181D-FL) cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1530 pTL61T with PT7A1 rrnG AT-H-19B nutR-tR1 -lac ZYA, AmpR This study
pRS1609 pT7A1-AT-trp t-lacZ, AmpR This study
pRS1695 nusA (WT-SKK) His-tagged, cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1696 nusA (G181D-SKK) His-tagged, cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
pRS1697 nusA (R258C-SKK) His-tagged, cloned at NdeI/SalI sites of pHYD3011 vector, AmpR This study
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NusA Dissociation Assays in the Presence of Cold Com-
petitors—For measuring the binding strength of WT and
mutant derivatives of NusA to the nut site in the presence of a
stalled EC, transcription reactions were performed in the pres-
ence of 100 nM lac repressor to form a roadblocked EC at the
lacO site present downstream of various terminators. The lac
repressor-boundDNA templates were immobilized on strepta-
vidin-coated magnetic beads (Promega) through streptavidin-
biotin interaction at their 5-end. The roadblocked ECs were
formed by chasing EC23 with 250 M NTPs along with a 20 nM
concentration of either 32P-labeled WT or R258C NusA for 2
min. Excess NTPs were then removed by thoroughly washing
the beads, followingwhich varying concentrations (10–200nM)
of unlabeled (cold) WT and R258C NusA proteins were added
as the competitors. 30 l of samples were removed at different
time points and fractionated into supernatant and pellet frac-
tions by holding the tubes on the magnetic stands. Half of the
supernatant (S) and the rest of the sample (S P, denoted as P
in the figures) weremixed with an equal volume of SDS loading
buffer. Fractions of NusA dissociated ((2S)/(S) (S P)) were
plotted against time, and the curves were fitted to a three-pa-
rameter hyperbolic binding equation of the form, y  y0 
((a*x)/(b  x)), where b denotes the amount of competitor at
50% dissociation, and a is the amplitude of the dissociation
curves.
Fluorescence Assays to Estimate the Kd of the NusA-RNA
Interaction—To measure the binding constants (Kd) of the
NusA-RNA interactions in isolation, we have monitored the
tryptophan fluorescence changes of the WT and R258C deriv-
atives of theNusA-SKK fragments. This fragment has two tryp-
tophan residues. Fluorescence experiments were performed in
a Hitachi FL7000 spectrometer at 25 °C. The excitation wave-
length was 295 nm, and the emission range was 310–400 nm.
Fluorescence intensities at 340 nm were plotted against
increasing concentrations of an HPLC-pure 20-mer RNA hav-
ing the rrnAT-box sequence. The Kd values were calculated by
fitting the binding isotherms to the equation, y yo (ab/(b
x)), where b denotes the Kd.
NusA-Rho Competition Assays for the Same or Overlapping
Binding Site(s)—Stalled ECs were formed, in the same way as
described earlier, either downstream of the AT-box (PCR-am-
plified from pRS1530 using the RS83/1127 oligonucleotide
pair) or in the terminator zone of the rho gene (PCR-amplified
from the chromosomal DNA using the RS1116/RS1142 oligo-
nucleotide pair). A C-terminal heart muscle kinase-taggedWT
Rho was used to radiolabel at its C-terminal. The presence of
this tag did not affect its activity (5). (i) In the experiments
where Rho was added prior to the competitor, 5 nM 32P-labeled
WT Rho together with 1 mM AMP-PNP were added to the
stalled EC for 5 min. The beads were washed, followed by the
addition of 200 nM cold competitors, and incubation was con-
tinued for another 5min, following which supernatant and pel-
let fractions were collected. (ii) In the experiments where Rho
and the competitors were added together, 5 nM 32P-labeledWT
Rho (1 mM AMP-PNP) and a 200 nM concentration of the
competitorswere added together to the stalled EC. Supernatant
and pellet fractions were collected after 5 min. The fractions of
Rho dissociated from the ECwere calculated as described in the
above mentioned dissociation assays. (iii) In the experiments
where competitors were added before Rho, 200 nM competitors
were added to the stalled EC, followingwhich 5 nM radiolabeled
Rho was added to the mixture. Other experimental conditions
were the same as above.
Nascent RNA-mediated RhoATPase Assays on the EC Stalled
Downstream of the AT-box—The stalled ECs were formed in a
similar way as in the RNA release kinetics experiments but
without using immobilized template. To obtain a sufficient
amount of RNA for the ATPase assays, the concentrations of
DNA template andRNAPwere increased 4-fold comparedwith
that used in the in vitro transcription assays. Rho 1 mM ATP
wasmixedwith [-32P]ATP (3000Ci/mmol), was then added to
the stalled ECs, both in the absence and presence ofWT/R258C
NusA, and the inorganic phosphate (Pi) releasewas observed on
polyethyleneimine thin layer chromatography sheets (Merck)
under 0.75 M KH2PO4 (pH 3.5) as the mobile phase. The com-
position of the assay mixture was 25 mM Tris-HCl (pH 8.0), 50
mM KCl, and 5 mM MgCl2. The reactions at the indicated time
points were stopped with 1.5 M formic acid. thin layer chroma-
tography sheets were analyzed by Fuji FLA 9000. The amounts
of [-32P]ATP and the released Pi were calculated from the
intensities of the spots of these products using ImageQuantTM
software.
Microarray—E. coliMG1655was transformedwith pCL1920
vector expressing WT and different NusA mutants (WT/
G181D/R258C). The genomic copy of the nusA was deleted by
P1 transduction (nusA:KanR). Two colonies from each strain
were grown in LB until the A600 reached0.4. The cell pellets
were dissolved in 1.5 ml of RNAlaterTM (Ambion). The RNA
isolation, microarray experiments, and gene expression analy-
sis were performed by Genotypic Technologies Pvt. Ltd. (Ban-
galore, India). Two types of Agilent arrays were used as
described below.
In the low density arrays, Agilent E. coli K12 microarray
slides in an 8000  15,000 format along with Agilent’s one-
color (cyanine 3-labeled targets) microarray-based gene
expression analysis were used. The total number of coding
regions available on the chip was 4294. The average number of
probes per coding region sequence was 3, and the total number
of probes designedwas 10,828. The total number of probes used
for non-coding region was 4380. For the Agilent high density
tilingmicroarray, the specificationswere as follows: format, 2
400,000; total number of genes covered, 4515; total number of
probes, 416,505, of which 249,903 probes correspond to the
genic region and 166,602 probes correspond to the non-genic
regions. Two independent biological replicates were used for
each strain. Only those genes showing a change of 1.5-fold
compared with the WT strain were considered. Microarray
data for the Rhomutants and those obtained in the presence of
bicyclomycin were reported earlier (21, 32). These were used to
compare with the data obtained for the NusA mutants.
RT-PCR and qRT-PCR Assays—To validate the microarray
data, RT-PCR and qRT-PCR for selected geneswere carried out
with the same strains as were used in the microarray experi-
ments. Two colonies from each strain were grown until A600 of
0.4. RNA was isolated from the bacterial pellets using the
RNeasy RNA isolation kit (Qiagen). In brief, 3 g of total RNA
NusA, General Antagonist of E. coli Rho-dependent Termination
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was used for DNase I treatment (for 15 min at 37 °C) and was
used for cDNA synthesis using the SuperScript III first strand
synthesis system (Invitrogen). 1 l of cDNA was used as tem-
plate for PCR in a 20-l reaction. The product from rpoC was
used as an internal control because it is expressed constitu-
tively. The RT-PCR products were run on 1.5% TAE-agarose
gels.
The qRT-PCR was performed in an Applied Biosystem 7500
PCR system using Cyber Green dye. The amount of product
formed was calculated by determining the Ct value (the mid-
point of the sigmoidal curve obtained by plotting the fluores-
cence intensity against the number of PCR cycles) for each sam-
ple. The 2Ct method was used for calculating the -fold
change (2Ct) in the RNA levels in the mutants with respect
to theWT, whereCt number of threshold cycle;Ct (Ct of
target gene)  (Ct of internal control); Ct  Ct of the
mutantCt of theWT.TheRNA level of rpoCwas used as an
internal control. The central part of each gene was used for
designing oligonucleotide pairs having comparableTm produc-
ing cDNA products of length 200–300 nt.
Western Blotting—Western blotting was employed to check
the levels of different derivatives of full-length NusA and NusA
SKK domain cloned in pCL1920 and pHYD3011 plasmids. For
full-length NusA, monoclonal antibody of NusA was used
(Neoclone), whereas for SKK fragments, an anti-His monoclo-
nal antibody (Qiagen) was used.Western blotting was also per-
formed to measure the in vivo concentrations of Rho in the
presence of WT and different nusA mutants using polyclonal
antibodies specific for Rho (see Fig. 10). In general, E. coli
MG1655 was transformed with pCL1920 and pHYD3011 plas-
mids having either nusA derivatives (WT/G181D/R258C) or
rho. In cases ofmeasurements of the in vivo level of Rho (see Fig.
10) or different NusA proteins (Fig. 2), after transformations
with the pCL1920 NusA plasmids, the genomic copy of nusA
was deleted by P1 (nusA:KanR) transduction. Each strain was
grown until A600 of0.4. The bacterial pellets were suspended
in 100l of SDS dye (0.5 M Tris, pH 6.8, 50% glycerol, 10% SDS,
2-mercaptoethanol, bromphenol blue) and boiled at 100 °C
for 10 min to obtain the cell lysates. Proteins in these lysates
were resolved on SDS-PAGE (12%), and subsequently the
Western blotting was performed by following standard proce-
dures using polyclonal antibody of the Rho protein. The blots
were viewed in a chemiluminescent detection system
FluorChemTM E (ProteinSimple).
Bioinformatics—The operonic arrangements of the genes
whose expressions were affected by both NusA and Rho
mutants were organized using information from the EcoCyc
database. Gaps between the genes were defined as intergenic
regions, which could be targets of Rho binding. To represent
the common genes as a subset of the two nusAmutants (G181D
andR258C), as well as subsets between a nusAmutant (G181D/
R258C) and the three rhomutants (N340S, G324D, and P279S),
respectively, different Venn diagrams were drawn. The crite-
rion of an identical gene or another gene from the same operon
being up-regulated in the two mutants (rho/nusA) was chosen
to denote the overlap.
Results
Nut Site-dependent Inhibition of Rho Function by NusA
Mutants—Using a genetic screen as described under “Experi-
mental Procedures,” we isolated a nusAmutant, G181D, that is
defective for Rho-dependent termination.We also constructed
an earlier reported nusAmutant, R258C, having a similar defect
(17).We have chosen E. coliMC4100 strains, each carrying one
of the four lacZ reporter cassettes Plac-H19B tR1-lacZYA (16),
Plac-tR1-lacZYA (22), PRM-trac-lacZYA (21), and Plac-trpt-lac-
ZYA (22) tomeasure the in vivo termination defects of the nusA
mutants. In these reporter cassettes, Rho-dependent termina-
tors tR1 (obtained either fromH-19Bor fromphages), trac, and
trptwere fused upstream to the lacZYAoperon. Thehigher the
amount of -galactosidase activity from each of the reporters,
the greater is the defect in the Rho-dependent termination.WT
and the mutant derivatives of NusA were expressed from their
own promoter cloned in a low copy plasmid (pCL1920). The in
vivo expression levels of NusA proteins from this plasmid were
close to the physiological level (Fig. 2A). It should bementioned
that in these strains, the chromosomal deletion of nusA leaves
behind the N-terminal fragment of NusA (7). However, this
fragment does not have any function in vivo because these
strains were not viable in the absence of theWT nusA supplied
from the plasmid (data not shown).
We made the following observations. (i) NusA mutants,
G181D and R258C, caused 3–5-fold enhancement in the -ga-
lactosidase activities compared with their WT counterpart
from the reporters having tR1 terminators (from the H-19B and
 phages; Fig. 2B). The effect of R258C NusA was more pro-
nounced. (ii) This enhancement was not observed from the
reporters having the trpt and trac terminators (Fig. 2B). Among
these terminators, only the tR1 terminators have an overlapping
NusA binding site, nutR (10) (Fig. 1C); hence, the termination
defects caused by these two NusA mutants were only observed
with the terminators having nut sites.
Next we studied the anti-Rho dependent termination effects
of WT and R258C NusA proteins in a purified system. We
performed in vitro transcription assays using a DNA template
where  nutR/tR1 and trpt terminators were fused downstream
of a strong T7A1 promoter (Fig. 2, C and D). In the in vitro
termination assays, Rho terminates transcription over a region
called a termination zone. We observed that in the presence of
both WT and the R258C NusA, this termination zone moved
toward the longer transcript side, indicating a delay in the ter-
mination process (Fig. 2C). This effect of NusA was not
observed at the trpt terminator that does not have an overlap-
ping nut site (Fig. 2D). The termination at tR1 was further
delayed by R258C NusA compared with WT. In addition to
this, a significant fraction of the transcript escaped the termi-
nation and reached the end of the template (run-off (RO); com-
pare the amounts of RO product indicated below the lanes)
when R258C NusA was used. This suggests that NusA on its
own is capable of delaying Rho-dependent termination in a nut
site-dependent manner, and this inhibitory effect is enhanced
by the R258C mutations in NusA. Because nut and rut sites
overlap (see Fig. 1C), it was not possible to make mutations in
the nut site without affecting the rut site; hence, we used a
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nut-less Rho-dependent terminator, trpt, to understand the
nut dependence of the NusA.
We localized these two NusA mutations in its SKK domain
that confers the RNA binding properties to NusA (Fig. 2E) (23).
Because they are in the RNA binding domain, it is possible that
enhanced inhibitory activities of these twomutants were due to
their tighter RNA binding to the nut site.
To test this, we determined the affinity of theWTandR258C
NusA-SKK domains for an RNA oligomer (20-mer) having
the nut site from the rrn AT-box (Fig. 1C). Isolated full-length
NusA does not bind to RNA due to the inhibitory effect of the
NusAN-terminal domain (10), so we used only the RNA-bind-
ing fragment of the NusA.Wemeasured the binding constants
(Kd) of these two NusA SKK domains by monitoring the
changes in their tryptophan (Trp-276 and Trp-334) fluores-
cence at 340 nm upon interaction with the increasing concen-
trations of the AT-box RNA oligomer (Fig. 2F). We observed
that the isolated SKK domain with R258C mutation has
4-fold higher affinity than itsWT counterpart. This indicates
that the intrinsic affinity of the NusA RNA binding domain for
the nut site increased due to the R258Cmutation. The obtained
binding constant of the WT SKK domain is consistent with
what has been reported earlier (10).
The above data indicate that the binding constant of the free
NusA for an RNA oligonucleotide is in the micromolar range,
which is quite moderate for an RNA-binding protein, and the
functional relevance of this low affinity NusA-RNA interaction
outside the EC is questionable. Due to the increase in local
concentrations, this affinity is likely to be enhancedwhenNusA
is bound to the EC, and also the interaction becomes more
functionally relevant; hence, below, we decided to estimate the
RNA binding properties of the WT and mutant derivatives of
NusA when bound to the EC.
Higher Concentrations of the Full-length and the SKK
Domain Fragment of WT NusA Produce the Same Inhibitory
Effects as the Two SKK Domain Mutants—If the enhanced
inhibitory effects of the NusA mutants are due to their higher
affinity for the nut sites, it is expected that the elevated concen-
trations of WT NusA would also elicit similar responses as the
NusAmutants.We increased the in vivo concentrations ofWT
NusA artificially by expressing it from the PBAD promoter
cloned in a high copy number (20–25) plasmid, pHYD3011
(see Table 1). This is a modified PBAD plasmid having a strong
ribosome binding site from a pET vector, which enables it to
express a very high level of any protein upon derepression. Due
to thesemodifications, it also expresses proteins to a significant
level even in the presence of the repressor. The expression was
induced by removing glucose, a repressor of PBAD, from the
medium. These strains were not maintained under uninduced
conditions to avoid any harmful effect, if any, due to the ele-
FIGURE 1. Descriptions of the NusA protein and the nut and rut sites. A, various functional domains of E. coli NusA as indicated. The boundaries of each
domain are shown by amino acid numbers. Crystal structures of each of the domains are also shown (Protein Data Bank entries 1L2F, 1WCL, and 1WCN) (29). B,
sequences of some bona fide NusA binding sites in E. coli. rrn AT, rrn operon antitermination box; nut L and R, N utilization sites from  phage. C, depiction of
overlapping rut and nut sites in the tR1 terminator sequence. Rut sites and boxA and boxB elements of the nut site are indicated. The termination zone is
indicated by an underline.
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FIGURE2.EffectsofNusAmutantson the in vivoand in vitro transcriptions.A,Westernblots showing the in vivo level ofWTandmutantNusAproteins expressed
either from chromosome or from pCl1920 plasmids. Amonoclonal antibody (Neoclone) of NusAwas used. A blot for the -subunit of RNAPwas used as a loading
control. Anti-polyclonal antibodywas used for this purpose. Signal intensity of chromosomalNusA (lane 1) was set as 1, and amounts of differentNusAproteins in
other lanes (lanes 2–4) were expressedwith respect to that. In lanes 2–4, MG1655 strain was transformedwith the indicated plasmids, followingwhich the chromo-
somalnusAwasdeletedbyP1transduction.Equalamountsofcells,as judgedbyA600,were loadedineachof the lanes. S.D.values (errorbars)wereobtainedfromthree
measurements. Prestained protein molecular weight markers are shown beside the gels to identify the protein size. Note that NusAmigrates as a higher molecular
weight protein. B, bar diagrams showing the -galactosidase activities obtained from the lacZ reporter cassettes fused downstream of the different (as indicated)
Rho-dependentterminators, trpt, trac,tR1, andH-19B tR1.BarsaregroupedaccordingtothenusAalleles,asstated.Theenhancements inactivities inthemutantalleles
are indicated by upward arrows. These enhancements indicate termination defects at the Rho-dependent terminators in the presence of mutant nusA alleles.
-Galactosidase activities are expressed in arbitrary units (A.U.). The error barswere obtained from five independent experiments. C andD, autoradiograms showing
the in vitro transcription assays performedon indicated linearDNA templates,where transcriptswere initiated from the T7A1promoter. Templates carry the Rho-de-
pendent terminators, nutR/tR1 (C) and trpt (D). Triangles, increasing concentrations of NusA ranging from5 to 200 nM, as indicated. The termination zone and the RO
products aremarked. The 0NusA lane represents the Rho alone condition. Amounts of RO in the presence of specific concentrations of NusA are indicated below the
gels. RNA length markers are indicated beside the gels. These values were calculated using the equation, [RO] [RO]/([RO] intensities of all of the bands in the
termination zone). E, schematic showing the locations of the point mutations in the structure of NusA (Protein Data Bank entry 1L2F) as spheres. F, changes in
fluorescence intensities of the tryptophan residues of the SKKdomainupon the additionof increasing concentrations of 20-mer oligo-RNAhavingAT-box sequence.
F and F0, final and initial intensities at 340nm, respectively. The averageof three independent titrationprofiles is plotted. The averageKd values indicated in theplots
are obtained by fitting the points to a hyperbolic curve.
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vated concentrations of NusA.We confirmed byWestern blot-
ting that from these constructs, the NusA level was elevated
3-fold upon induction (data not shown). We measured the
-galactosidase activities in the same way as described above.
We observed that at elevated concentrations, WT NusA was
capable of inhibiting the Rho-dependent termination at the tR1
terminator to the same extent as the two NusA mutants (Fig.
3A). The -galactosidase activity, which is the measure of
the read-through at a terminator, was observed to increase
3-fold. This concentration-dependent inhibitionwas also nut
site-specific because it was not observed at the trac terminator
(21), which is devoid of this site (Fig. 3B).
If NusA binding to the nut site is the only requirement to
inhibit Rho action, then higher concentrations of the RNA
binding domain of NusA, the SKK domain fragment (23.8 kDa,
amino acids 113–348; see Fig. 1A), should also exhibit the same
effect as the full-length NusA. We expressed the SKK domains
each having either the WT or the two mutations in the same
way as stated above from the inducible PBAD promoter. Higher
levels of expression (4-fold) of these NusA fragments were
also confirmed by Western blotting (data not shown). We
observed a5-fold increase in -galactosidase activities at the
tR1 terminator in the presence of elevated concentrations of all
of the three derivatives of the SKK domain (Fig. 3C). This
increase was not observed at the trac terminator (Fig. 3D).
Therefore, binding of the isolated SKK domain in trans to the
nut site is sufficient for the Rho inhibition.
In Fig. 3, A and C, we observed a nonspecific increase of
-galactosidase activities in the presence of the vector itself.We
think that this arose due to the titration of the Rhomolecules by
the high level of untranslated transcripts initiated from the
strong PBAD promoter under induced conditions.
The aforementioned results indicated that (i) the NusA-me-
diated inhibition of Rho occurred through the nut site binding
of its SKKdomain, and (ii) Rho-inhibitory activity of R258C and
G181D NusA is probably due to their enhanced affinity for the
nut site. In this regard, it should be mentioned that the
enhanced inhibitory effect of these two mutants suggests that
the WT NusA has an intrinsic Rho-inhibitory activity (also see
Fig. 2C,WTNusA panel); hence, these mutants with enhanced
inhibitory activities could be used as tools to understand the
mechanism of this inhibition.
Estimating the Higher Affinity of the NusA Mutant When
Bound to a Stalled EC—To measure the higher affinity of
R258C NusA mutant for the nut site as well as the stability of
the NusA-EC complex, we employed competition assays with
the purified components. We measured the dissociations of
WT and mutant NusA proteins from the ECs stalled at the lac
operator sites present either close to the nut site (60 nt down-
stream; Fig. 4A, left, Template I) or away from it (250 nt
downstream; Fig. 4A,middle,Template II) or 63 nt downstream
of a terminator that is devoid of the nut site (Fig. 4A, right,
Template IIIwith the trpt terminator). The ECs were stalled at
the lacO sites on the different templates in the presence of lac
repressor molecules. The NusA-nut interaction weakens as the
EC moves away from the nut site, so it is likely that NusA dis-
sociation would happen more readily from the stalled ECs
formed on template I. Due to the absence of the nut site, the
FIGURE 3. Effects of overexpression of full-length and SKK domain of NusA on the in vivo transcription.-Galactosidase activities from the lacZ reporter
fused downstreamof Rho-dependent terminators, H-19B tR1 (A and C) and trac (B andD). The effects of overexpression of different derivatives of full-length (FL)
NusA (A and B) and its SKK fragment (C andD) are shown. Concentrations of these two species were varied by adding () or omitting () 0.1% glucose (Glu) as
theywere expressed from the PBADpromoter. In vivo levels of full-lengthNusA and SKK fragmentswere verified byWestern blotting (data not shown). Because
the in vivo levels of different NusA derivatives were similar (3-fold enhancement upon induction), we did not attempt to normalize the -galactosidase
activities. S.D. values (error bars) were obtained from five independent measurements. vector, empty plasmid without the nusA. A.U., arbitrary units.
NusA, General Antagonist of E. coli Rho-dependent Termination
APRIL 8, 2016•VOLUME 291•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 8097
 by guest on M
ay 28, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
interaction would also be weaker on template III. It should be
mentioned that the NusA N-terminal domain interacts with
RNAP, which also contributes to the stability of the NusA-EC
complex formation (24). However, NusA SKK domain-RNA
interactions are the major component that contributes to sta-
bilizing this complex formation, because very high concentra-
tions of the free NusA N-terminal domain are required to
observe the interaction of this fragment with EC in the in vitro
experiments (24). Under our experimental conditions,70% of
the NusA molecules remained associated with the EC in the
absence of any competitor (data not shown). In these experi-
ments, both theWT and the R258CNusA proteins were radio-
labeled with 32P at their heart muscle kinase tag (used to radio-
label proteins) sequence. The stalled ECs were immobilized on
magnetic beads using a biotinylated DNA template so that the
dissociation of [32P]NusA could be measured in the superna-
tant fractions. Due to the poor solubility of the G181D NusA
protein, we did not attempt any in vitro experiments with it.
In these experiments, at first a 23-mer EC (EC23) was formed
by omittingUTP from the reactionmix (see “Experimental Pro-
cedures”), which was subsequently chased with all of the NTPs
together with either radiolabeledWTor R258CNusA proteins.
NusA-bound stalled ECs (at the lac operator sites in the pres-
ence of lac repressor) formed on templates I (Fig. 4, B and C,
left), II (Fig. 4, B and C, middle), and III (Fig. 4, B and C, right)
were then competed out by adding different concentrations of
FIGURE 4. Cold competition assays of radiolabeled NusA bound to stalled elongation complexes. A, schematics showing the stalled EC formed down-
stream of Rho-dependent terminators by the lac repressor (lacI). On templates I (left) and II (middle), ECs are stalled 60 and 250 nt downstream of the nut site
of  nutR, respectively. In template III (right), trpt, lacking any nut site, is located 63 nt downstream of the terminator. All of the templates were immobilized to
streptavidin-coatedmagnetic beads through a streptavidin-biotin bonding at their 5-end. B, fractions of dissociated radiolabeled NusA ([32P]NusA) bound to
the stalled EC on template I (left), template II (middle), and template III (right). Different derivatives of [32P]NusA bound to stalled ECs are indicated. C, plots
obtained from the fraction of dissociatedNusA in the presence of increasing concentrations of cold competitors,WT, and R258CNusA. Stalled ECs on template
I (left), template II (middle) and template III (right) were bound to eitherWT (WT-EC) or R258C (R258C-EC) NusA. Data pointswere fitted to a hyperbolic equation.
Concentrations of cold competitor corresponding to 50% change are indicated. In all of the experiments, S.D. values (error bars) were calculated from three
independent experiments.
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either unlabeled (“cold”) WT or R258C NusA. The amounts of
the competitors required to dissociate 50% of the EC-bound
radiolabeled NusA proteins, indicated in the plots, gave quan-
titative measures of the stability of each of the NusA-EC com-
plexes. The lower the concentration of the cold competitor
required for competition, the lesser is the stability of the
NusA-EC complex.We observed the following. (i) 50% dissoci-
ation of both the WT and R258C NusA proteins bound to the
ECs stalled on template I was exerted by their respective cold
counterparts at a concentration of 4 nM (Fig. 4C, left). This
facile dissociation by the cold competitors also indicates that it
is an equilibrium methodology to estimate the stability of the
complexes. (ii) On the same template, EC-bound R258C NusA
required17-fold higher concentrations of cold WT NusA to
obtain 50% dissociation (Fig. 4C, left). (iii) This cold competi-
tion was more facile when the labeled NusAs were part of EC
stalled on the template II (Fig. 4C,middle), which indicates that
the stability of NusA-EC as well as NusA-RNA interactions
weakens when the EC moves away from the nut site. (iv) This
stability was significantly reduced when the EC was stalled
downstream of the trpt terminator sequence that is devoid of
the nut site (template III; Fig. 4C, right). However, compared
with template II, higher concentrations of cold competitors
were required to induce dissociation of EC-bound NusA pro-
teins on this template. Probably, the presence of someunknown
“nut-like” sequences in the trpt terminator could have
improved the affinity of NusA.
These data further support the results obtained in Fig. 2F,
which suggest an enhanced Rho inhibition by R258CNusA due
to its higher affinity for the nut site. However, the enhanced
stability of this mutant for the EC was observed only when the
EC was in the vicinity of the nut site.
NusA Binding to Nut Site(s) Delays the Loading of Rho at the
Rut Site(s)—The aforementioned results strongly indicated that
theNusA-mediated inhibition of Rho function is due to a direct
interaction of the former with the nut site. Next, in order to
identify the step(s) of Rho-dependent termination affected by
this NusA-nut interaction, wemeasured the Rho-induced RNA
release from an EC stalled downstream of either tR1 or trpt
terminator (Fig. 5A). The Rho action wasmeasured in the pres-
ence of eitherWTor R258CNusA. In these experiments, the in
vitro transcription was initiated from the T7A1 promoter, and
FIGURE 5.Assays to showdirect NusA-Rho competition for the overlapping nut and rut sites. A, schematic showing the configuration of the stalled ECs at
a LacI roadblock (RB) downstreamof eithertR1or trpt terminators. DNA templateswere immobilized tomagnetic beads via a streptavidin-biotin linkage. This
immobilization enables us to measure the released RNA in the solution. Rut sites of each of the terminators are indicated. Autoradiograms show the time
courses of RNA release from the ECs stalled downstream of either tR1 (B) or trpt (C) terminators. These time courses were obtained either in the absence of
NusA or in the presence of WT or R258C NusA. Inverted triangles denote the increasing time as indicated. S and P, one-half of the supernatant and one-half of
the supernatant plus pellet fractions, respectively.D and E, plots of fractions of released RNAobtained in B andC, respectively, against time. The indicated rates
of RNA release (k) for each curve were calculated from the exponential fitting of the curves. The fraction of released RNA was estimated from the expression,
[2S]/([S] [S P]). S.D. values (error bars) were calculated from three independent measurements.
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the elongation occurred either through the tR1 (Fig. 4, Tem-
plate II) or the trpt (Fig. 4, Template III) terminator regions to
reach the lac operator/repressor-mediated roadblock. DNA
templates were immobilized to magnetic beads to measure the
released RNA in the supernatant (Fig. 5, B and C).
We observed that both the WT and R258C NusA proteins
(Fig. 5, B and D) slowed down the Rho-induced rate of RNA
release significantly when the ECs were stalled downstream of
the tR1 terminator. Similar effects were not observed from the
ECs stalled downstream of the nut-less trpt terminator (Fig. 5,
C and E).
These results indicated that there could be a direct competi-
tion between Rho and NusA for the nut/rut sites. Consistent
with these observations, we have earlier shown that the nut and
rut sites overlap in the spacer region of the nutR/tR1 sequence
(see Fig. 5 of ref. 22 and Fig. 6 of Ref. 25). The presence of NusA
delays the RNA loading as well as the RNA-dependent activa-
tion step(s) of Rho, which is reflected as a slow rate of RNA
release by Rho. We also observed that R258C NusA did not
induce enhanced pausing by the elongating RNAP,which could
have been an alternative way of delaying the Rho-dependent
termination (data not shown).
Competition between Rho and NusA for the AT-box of rRNA
Operons—The AT-box in the untranslated ribosomal operons
is responsible for the antitermination of primarily the Rho-de-
pendent termination (26, 27). A complex of NusA,NusB, NusE,
and other ribosomal proteins bound to the AT-box may pre-
vent Rho loading onto the mRNA and thereby bring about the
transcription antitermination in this operon (11). This AT-box
comprises a NusA-binding site, the boxA sequence, and also an
overlapping Rho-binding site (Figs. 1B and 6A (10)). The afore-
mentioned results and the composition of the AT-box of the
ribosomal operon led us to hypothesize that the NusA-medi-
ated inhibition of Rho-dependent termination is likely to be a
major component of the rRNA-antitermination event, and this
inhibition occurs due to a direct NusA-Rho competition for the
AT-box.
To test the hypothesis, we cloned a 22-base pair AT-box
sequence of rrnG (29) (Fig. 6B) upstreamof the trpt terminator
that is devoid of anyNusA-binding site.Wemeasured the tran-
scription termination at the trpt terminator that is fused
downstreamof theAT-box, both in the absence andpresence of
WT and R258C NusA (Fig. 6C). The transcription termination
patterns in the presence (T7A1-AT-trpt) and absence (T7A1-
trpt) of the AT-box have been compared side by side (Fig. 6C).
Transcription assays were performed with immobilized DNA
templates to assess the terminated transcripts in the superna-
tant fractions. We observed that the presence of the AT-box
induced a significant delay in transcription termination in
a NusA-dependent manner, and this delay increased the
amounts of RO transcripts. The presence of R258C NusA pro-
duced a higher level of RO products but, unlike the tR1 termi-
nator (Fig. 2B), did not producemore delayed termination zone
compared with its WT counterpart. This could be because of
fewer pausing sequences in this template, such that the EC
could have escaped from the action of Rho. Similar to the case
of tR1 terminator, R258CNusA presumably has a higher affin-
ity for the boxA sequence of the AT-box. These results suggest
that even in the absence of other Nus factors (11), binding of
NusA to the AT-box is sufficient to bring about Rho inhibition
as well as the in vitro antitermination. We restricted our study
to only the in vitro experiments because the role of NusA in
rRNA antitermination would have been difficult to identify in
vivo in the presence of all of the other essential Nus factors.
Next, we designed experiments to directly demonstrate the
Rho-NusA competition for the AT-box of the nascent RNA.
We stalled the EC, 44 nt downstream of the AT-box (Fig. 6D),
by using the lac repressor. The template was immobilized in a
similar way as described in the legend to Fig. 4. We performed
three types of competitions. In the first case, both radiolabeled
Rho and the different cold competitors (the SKK domain frag-
ment with R258C mutation (R258C-SKK) and AR1–2 NusA
that is devoid of AR1 and AR2 domains) were mixed together
and added to the stalled EC (Fig. 6E). In the second case, Rho
was added to the EC prior to the competitors (Fig. 6F). In the
third case, NusA derivatives were added to the EC prior to the
Rho (Fig. 6G). Both the SKK domain and the NusA devoid of
AR1–2 domains are capable of binding to RNA in trans (10),
and the latter construct was used because the presence of AR1
and AR2 domains inhibits NusA from binding to the RNA (30).
To avoid the translocase activity of Rho, instead of ATP, its
non-hydrolyzable analogue, AMP-PNP, was used. In the pres-
ence of ATP or AMP-PNP, Rho forms a translocase-competent
complex on the rut site (31). The amounts of cold competitors
were a 150- and 600-fold molar excess of the radiolabeled Rho
(also see “Experimental Procedures”). The amount of Rho dis-
sociated was estimated from the supernatant fractions. The
experiments described in the legend to Fig. 6E (Rho and com-
petitor added together) were also repeated on a control tem-
plate that was devoid of the AT-box (T7A1-trpt) (Fig. 6H).
We observed that under two conditions, the radiolabeled
Rho was competed out efficiently: when Rho was mixed
together with the cold competitors before the addition to the
EC (Fig. 6E) and when it was added after the competitors were
added to the stalled EC (Fig. 6G). This competition was not
evident on the template lacking the AT-box (Fig. 6H) and when
the Rho was added to the EC prior to the competitors (Fig. 6F).
Therefore, the specific Rho-NusA competition occurs at the
recognition step of the AT-box, and the competition does not
occur if either Rho-RNA or NusA-RNA complexes were
formed first. These results also indicated that the presence of
overlapping binding sites for Rho and NusA blocks the entry of
one species in the prior presence of the other.
We also checked whether R258C NusA has a higher affinity
for the AT-boxwhen it is part of the EC (Fig. 7,A–C). Using the
same stalled EC as described in the legend to Fig. 6D and fol-
lowing the same procedures as described in the legend to Fig. 4,
we observed that, compared withWT, R258CNusA-bound EC
required significantly higher concentrations of the WT NusA
than the cold competitor, which indicated that this mutant
NusA also has higher affinity for the AT-box, which is consis-
tent with what we observed with the isolated AT-box RNA
oligomer (Fig. 2F).
If this competition for binding to the AT-box is functionally
relevant, thenNusAwould reduce the rate of the nascent RNA-
dependentATPase activity of Rho.Weused the same stalled EC
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FIGURE 6. Rho-NusA competition at the AT-box of an rRNA operon. A, schematic showing the AT-box sequence of E. coli rrnG operon together with the
flanking regions. B, details of the T7A1-AT-box-trpt construct. The T7A1 promoter, AT-box sequence preceding the 16S RNA gene of rrnG operon, and the rut
sites of the trpt terminator are indicated. C, autoradiograms showing in vitro transcription assays on T7A1-trpt and T7A1-AT-trpt templates under various
indicated conditions. The termination zones (dashed lines) and the RO products are indicated. The amounts of RO product in each transcription reactions are
shown below each lane. [RO]was calculated as [RO]/([RO] total band intensities in the termination zone). RNA lengthmarkers are indicated. S.D. values (error
bars) were calculated from 2–3 independent experiments. D, schematic showing an EC stalled 44 nt downstream of the AT-box sequence using LacI as a
roadblock. The AT-box region is the target of Rho as well as NusA fragments (SKK and AR1–2 NusA) having the RNA-binding domains. E–G, autoradiograms
showing the amounts of radiolabeled Rho in supernatant (S; half of the supernatant) and pellet (P; half supernatant  pellet) fractions in the presence of
different amounts of the competitors added either with Rho (E) or after adding Rho (F) or before adding Rho (G). Fractions of dissociated Rho in different cases
are given below each gel. Fractions of dissociated Rho were calculated as [2S]/([S]  [P]). H, autoradiograms showing a similar competition experiment
described inD except that the EC was stalled downstream of the trpt terminator, which lacks a bona fide nut site. This template has been described in Fig. 5A.
S.D. values (error bars) were obtained from 2–3 independent measurements.
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described in the legend to Fig. 6D for measuring the ATPase
activity of Rho using the nascent RNA exiting from the EC as
the substrate, both in the absence and presence of WT and
R258C NusA proteins (Fig. 7, D and E). We observed that the
rate of ATP hydrolysis of Rho was reduced by2–3-fold in the
presence of both the WT and R258C NusA proteins. These
assays strongly indicated that the Rho-NusA competition
observed by the binding assays described above (Fig. 6, E–H) is
also functionally significant.
Therefore, these results strongly suggest the existence of a
direct Rho-NusA competition for the AT-box sequence under
an in vitro setup, which could be an important component in
preventing Rho-dependent termination of this untranslated
operon.
Genome-wide Pattern of Rho-NusA Competition—Results so
far have convincingly indicated that at certain well character-
ized terminators, NusA inhibits Rho function by a direct com-
petition for the same or overlapping binding sites on the RNA.
This raises a possibility of the existence of this type of compe-
tition in many other operons, which in turn would lead to a
generalized negative regulation of Rho-dependent termination
by NusA. To test the hypothesis of the existence of this
genome-wide negative regulation of Rho, we performed both
low density and high density (Agilent tiling arrays) microarray
analyses of mid-log phase MG1655nusA strains expressing
WTormutantnusA (G181DandR258C) genes froma low copy
number pCL1920 plasmid.
We plotted the -fold changes in gene expression in different
nusA mutants relative to that of the WT (signal intensity with
respect to the WT; Fig. 8, A, B, D, and E). Because these two
nusA mutants caused a defect in Rho-dependent termination
(Fig. 2), we interpreted the up-regulations in different genes/
operons as the consequences of defects in Rho-dependent ter-
mination (Fig. 8,A andB). This up-regulation is consistent with
what was reported for theMDS42nusA strain (6).We ignored
the down-regulated genes because they might have arose from
indirect effects.We observed that a significant number of genes
were up-regulated in these two nusAmutants (Fig. 8, A and B).
In addition to this, close to 100 different non-coding regions,
mostly the intergenic ones, were also up-regulated (Fig. 8, D
and E). The list of all of the up-regulated genes is given in
supplemental Fig. S1. A significant number of up-regulated
genes/operons (supplemental Fig. S1 and Fig. 8C) as well as
intergenic regions (supplemental Fig. S2A and Fig. 8F) were
common between the two nusA mutants, which indicates the
reliability and robustness of the microarray data. It should be
mentioned that in addition to its altered RNA binding proper-
ties, G181D mutation makes NusA conformationally unstable,
which could have indirect influence on global gene expression
patterns. We believe that this might have reduced the overlap
between the microarray profiles of these two NusA mutants. It
should be noted that the number of genes/operons affected by
these two NusA mutants was not as high as that observed for
FIGURE 7. Effects of R258CNusA at the AT-box. A and B, autoradiograms estimating the stability of the complexes formed between radiolabeledWT/R258C
NusA and stalled EC. The same template as described in the legend to Fig. 6Dwas used to form the stalled ECs. The sameprocedures as described in Fig. 4were
used to perform the competition assays using “cold” WT NusA as competitor. The amounts of dissociated radiolabeled WT or R258C NusA proteins were
estimated from the S (half of the supernatant, [S]) and P (pellet plus the rest of the supernatant, [S P]) fractions. C, curves showing the fractions ([2S]/([S]
[S  P]) of labeled WT/R258C NusA dissociated from the stalled EC upon the addition of increasing concentrations of the cold competitors. Amounts of
competitors required to bring about 50%dissociation of the radiolabeledNusA are also indicated. S.D. values (error bars) were obtained from2–3 experiments.
D, representatives thin layer chromatography plates showing the 32Pi release from [-
32P]ATP due to the RNA-dependent ATPase activities of Rho both in the
presence and absence of WT/R258C NusAs. In these experiments, Rho was added to the stalled ECs bound to either WT or R258C NusA, as described in
the legend to Fig. 6D. Rho utilizes the nascent RNA of the stalled EC to hydrolyze ATP. E, fractions of ATP hydrolyzed as calculated from the signal intensities of
the spots in the thin layer chromatographyplateswereplottedagainst time.Symbolsaredescribed in the key. RatesofATPhydrolyzes calculated fromthe linear
fittings of the points are indicated. S.D. values (error bars) were obtained from three sets of measurements.
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the microarrays obtained in the presence of the Rho inhibitor
bicyclomycin (6) or different Rho mutants (21, 32).
If a direct competition betweenNusA and Rho occurs during
the gene expressions from different parts of the genome, both
theNusA andRhomutants defective for Rho-dependent termi-
nation are likely to produce overlapping up-regulated gene
expression profiles in themicroarrays.We compared the NusA
mutant profiles with that obtained earlier (21, 32) with the ter-
mination-defectivemutants of Rho,N340S, G324D, and P279S,
as well as in the presence of the Rho inhibitor bicyclomycin.We
observed that either a high number of the same genes or the
genes of the same operons were up-regulated when Rho func-
tionwas impaired or in the presence of NusAmutants (Fig. 8,G
and H; see supplemental Fig. S1 for the full list). About 60% of
the up-regulated genes in theNusAmutantswere also observed
to be up-regulated when Rho function was affected (Fig. 8H).
We observed that some of the up-regulated intergenic regions
aswell as their neighboring regionswere also shared by both the
NusA and Rho mutants (supplemental Fig. S2B). These results
suggest that although the number of up-regulated genes is
lower in the NusAmutants, themajority of them are also found
to be up-regulated in the different Rhomutants as well as in the
presence of bicyclomycin. This is indicative of a widespread
Rho-NusA competition.
To validate the above microarray data, we measured the in
vivo RNA level of some selected genes in NusA and Rho
mutants by qRT-PCR (Fig. 8, H–J). The RNA levels for a few
intergenic regions (Fig. 9A) were measured by RT-PCR (Fig.
FIGURE 8.Microarray profiles and their validations by q-PCR. A and B, show the plots of microarray profiles of the coding regions (genes) obtained from
MG1655rac strains expressingdifferentnusAmutants as indicated. The ratio of thehybridization intensities obtained fromWTanddifferentmutants gave the
measureof the -fold changes that is expressed in log2 scale asper the convention.Up-regulatedgeneswith1.5-fold changes are shown. Eachgene is covered
by60 probes, and the averages of the -fold change values obtained from each of the probes were assigned as the -fold change values of each gene. C, Venn
diagram showing the number of overlapping genes and operons between the two nusAmutants.D and E, microarray profile plots for the non-coding regions
obtainedunder the sameconditions as inAandB. The coordinate at themidpointof eachof the intergenic regionswas considered forplotting. F, Venndiagram
showing the overlaps between the non-coding regions of the two NusAmutants. G, Venn diagrams showing the numbers of overlapping genes and operons
between theNusA (R258C andG181D) and the Rhomutants (N340S, G324D, P279S) and those obtained in the presence of bicyclomycin (BCM).H, overlapping
patterns of total number of up-regulated genes obtained in all of the NusA and Rho mutants together with those obtained in the presence of the BCM. I–K,
validations of the microarray data of the indicated genes by qRT-PCR. In vivo levels of RNA of the up-regulated genes in the presence of the NusA mutants,
G181D (H) and R258C (I), and the Rho mutant, N340S (J). mRNA levels are expressed as -fold changes of the CT values (threshold cycle) obtained from the
qRT-PCR as per the convention, details of which are given under “Experimental Procedures.” S.D. values (error bars) were calculated from the two biological
replicates. y axis breaks are used to accommodate the wide range of -fold change values for different genes.
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9B).We have chosen the genes yhil, yjhQ, cysQ, tdcD, rbsR, gfcE,
fimD, wecF, mgtA, racR (from the rac prophage), and rho for
qRT-PCR, based on the following criteria: (i) highly up-regu-
lated genes in NusA mutants, (ii) common up-regulated genes
between the NusA and the Rhomutants, and (iii) other genes
of the same operon where one gene is up-regulated by the
NusA mutants. We observed that relative mRNA levels of all
of these genes were significantly high in both the NusA and
Rho mutant strains, thus validating the microarray data. Up-
regulation of hundreds of genes together with intergenic
regions in the NusA mutants and the overlap of a significant
number among them with the microarray profiles of the Rho
mutants (Fig. 8H and supplemental Figs. S1 and S2B)
strongly indicate that NusA-mediated inhibition of Rho-de-
pendent termination is a genome-wide phenomenon.
The best characterized physiological functions that are influ-
enced by the Rho-dependent termination are as follows: (i)
prophage gene silencing (6) and maintaining their lysogenic
states (33), (ii) regulation of small RNA expression (34), and (iii)
riboswitch formations (8). We probed the up-regulation status
of the genes involved in these functions in both the NusA and
Rho mutants. Tables described in supplemental Fig. S2C
revealed that many prophage genes are up-regulated in the
NusA mutants, and a significant proportion of that or the
neighboring genes from the same prophage are also up-regu-
lated in the Rho mutants. An increase in the qRT-PCR signal
(Fig. 8, I–K) of the rac prophage gene, ydaF, validates the
microarray profile. We have observed a few small RNAs
(supplemental Fig. S2D), and an Mg2 sensor riboswitch-con-
trolled gene,mgtA (Fig. 4,H–J, and supplemental Fig. S1,mgtA
is highlighted in supplemental Fig. S1) was expressed at a high
level in both the NusA and the Rho mutants. These results
indicate that important physiological functions that are under
the control of Rho-dependent termination are also the target of
NusAantagonism.However, because bothNusAandRhobind-
ing sequences are quite ambiguous, we failed to predict and
locate such sequences in these operons.
Among the genes tested, tdcD, gfcE, fimD, and wecF are part
of very long operons (supplemental Fig. S2E), and transcrip-
tions of those would be ideal targets for Rho-dependent termi-
nation. A closer look into the microarray data revealed that
many of the genes of these operons are significantly up-regu-
lated in the presence of both theNusA (G181D andR258C) and
Rho mutants (N340S/G324D/P279S; in supplemental Fig. S2E,
see the tables for the -fold changes; Rho data were obtained
fromRefs. 21 and 32). These data are suggestive of the existence
of Rho-NusA competition in these long operons.
The classical role of Rho-dependent termination is to termi-
nate transcription of the untranslated operons because the long
stretches of unstructured naked RNAs are the targets of Rho
(35). Fig. 8, D and E, revealed that close to 100 intergenic
regions were up-regulated in the nusA mutants. Some of the
FIGURE 9. Analyses of the microarray data of the non-coding regions. A, a7.7-kb non-coding region due to the presence of many pseudogenes. This
region has been highly up-regulated in both of the NusAmutants (Fig. 8,D and E).Underlined subregions are up-regulated in both the NusA and Rhomutants.
Horizontal bars of different styles indicate different Rho and NusAmutants, as indicated. The values of the -fold changes in up-regulation are indicated against
eachmutant.B,mRNA levels fromtwoof thenon-coding regions, ydbA_2and rhsE, estimatedbyRT-PCR. Productsweremade fromthe total RNAobtained from
the strains expressing the indicatedNusAandRhomutants. A significant increase in the amount of RT-PCR signals in themutant strainswasobserved. The rpoC
product was an internal control. C, examples of highly up-regulated genes (in black) in NusA and Rho mutants that are part of operons with stretches of
untranslated regions. Gaps between the genes in each of the operons are likely to be the untranslated regions.
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same regions as well as several of their neighboring regions (up
to 300-nt regions upstream or downstream) were also up-reg-
ulated in the Rho mutants (see supplemental Fig. S2B and Ref.
32). A closer look into the tiling array profile revealed that a
7.7-kb region (dotted boxes in Fig. 8,D andE, and bracketed in
supplemental Fig. S2A), crowded with intergenic regions, is
highly up-regulated in both of the nusAmutants (Figs. 8 (D and
E) and 9A). The presence of several pseudogenes (as per the
EcoCyc database; Fig. 9A) formed different subregions of the
long stretches of untranslated regions that are up-regulated not
only in NusA mutants but also in the different Rho mutants
(indicated in Fig. 9A). We have validated the up-regulation of
the microarray data of two of the untranslated regions corre-
sponding to the pseudogenes by RT-PCR (Fig. 9B). We also
noticed that genes that were highly up-regulated in the NusA
and Rho mutants have many untranslated regions (Fig. 9C).
These untranslated regions are likely to have Rho-binding
site(s). Indeed, an RNA secondary structure prediction pro-
gram, M-fold, predicted that many of these regions have the
signature of the rut sites that are characterized by high C/G
ratio with favorable free energy to remain unstructured (data
not shown). The aforementioned detailed genome-wide
analyses strongly suggest a pattern of overlapping existence
of Rho targets and NusA binding sites on the same RNA of
many operons that is likely to lead to functional competi-
tions between these two factors and thereby support our
proposed hypothesis of NusA-mediated global antagonism
of Rho-dependent termination.
NusA-Rho Competition in the rho Operon—We observed the
up-regulation of rho in the presence of NusA mutants (Fig. 8 (I
and J) and supplemental Fig. S1), which indicates that expres-
sion of the rho operon itself could be under NusA competition.
The rho gene is preceded by an untranslated region (rhoL), part
of the sequence of which has a very favorable C/G ratio (3) for
becoming a potential rut site (Fig. 10A). This Rho-binding site is
responsible for the feedback regulation present in this operon
(36). We probed the NusA-mediated inhibition of the Rho-de-
pendent transcription termination in the rho operon.
We performedmultiple-round transcriptions of a DNA frag-
ment containing a part of the rho operon (Fig. 10A; see the
schematic) having the rho promoter, Prho, from which the in
vitro transcription was initiated (Fig. 10B). Rho-dependent ter-
mination occurred at the 5-proximal region of the rho gene
(indicated in Fig. 10B by dashed lines and also in Fig. 10A).
Similar to that observed in Figs. 2 and 6, WT and R258C NusA
delayed the termination zone, and in their presence a signifi-
cant amount of transcript reached the end of the template (RO)
without being terminated (Fig. 10B). The amount of RO prod-
uct in the presence of R258CNusAwasmuchhigher, indicating
its higher inhibitory effect on Rho. Thus, it is likely that the
untranslated region preceding the rho ORF harbors a NusA
binding site.
In order to provide further evidence for the existence of this
NusA binding site, we monitored the dissociation of Rho from
an EC stalled in the termination zone of the rhoORF using the
lac repressor as a roadblock (Fig. 10C). The amount of dissoci-
ation of radiolabeled Rho from the EC was estimated in the
presence of NusA SKK domain and AR1–2 NusA as compet-
itors. Competition experiments were performed essentially fol-
lowing the same procedures as described in the legend to Fig. 6.
Assays were performed on immobilized templates so that the
amount of released radiolabeled Rho could be measured in the
supernatant fractions (Fig. 10, D and E). Similar to what is
observed in Fig. 6, Rho was efficiently competed out on this
template when it was added to the EC together with the two
competitors (Fig. 10D), and this competition was negligible
when Rho was added before the competitors (Fig. 10E). These
results strongly suggest a Rho-NusA competition for the same
or overlapping site(s) on the nascent RNA of the Rho leader
region.
The Rho protein level increases when Rho-dependent termi-
nation is compromised (36). Therefore, it is expected that
NusA-mediated inhibition of Rho-dependent termination in
this operon should also increase the level of Rho, and this
increase would be much higher in the presence of NusA
mutants, G181D and R258C. We measured the in vivo level of
Rho protein in the presence of both theWT and mutant NusA
by Western blotting using a polyclonal antibody raised against
Rho (Fig. 10F) and observed a significantly higher level of Rho
expression in the presence of these two mutants. This further
reinforced our proposal of the existence of NusA-mediated
inhibition of Rho-dependent termination of the rho operon.
Discussion
Recent genomic studies (6, 7, 32) have revealed the presence
of genome-wide targets of Rho-dependent termination, which
are mostly required to prevent unwanted gene expressions.
However, the inherent less specific nature of its RNA binding
sites (rut sites) poses the danger of unwanted termination
events, and not much is known about how to minimize this
event. Once Rho is committed for translocation along the RNA,
it may not be controlled because this mechanical process is
irreversible. The rut site recognition step is likely to be the best
point to control Rho. In principle, many single-stranded RNA
binding proteins could block the rut recognition step by func-
tioning as direct competitors. Here, we have provided the fol-
lowing evidence to establish that the transcription elongation
factor NusA functions as a general antagonist of Rho by com-
peting for the same or overlapping sites on the mRNA. (i) We
have shown that the two NusA-SKK domain (RNA binding
domain)mutants as well as the isolated SKK fragment are capa-
ble of inhibiting Rho-dependent termination both in vitro and
in vivo, and this inhibition was nut site-dependent (Figs. 2 and
3). SKK domain mutations increase the affinity for the nut site
(Fig. 2F). (ii) This inhibition originates from the direct compe-
tition between overlapping nut and rut sites (Fig. 4), which
delays the Rho loading onto the rut sites (Fig. 5). (iii) The exist-
ence of direct competition between Rho and NusA was shown
during the antitermination of Rho-dependent termination at
the rRNA operon (Figs. 6 and 7) and as a part of the feedback
mechanism of the rho expression (Fig. 10). (iv) Finally, high
resolution tiling microarrays revealed the genome-wide pres-
ence of overlapping targets of NusA and Rho, indicating the
existence of NusA-mediated antagonism of Rho in many oper-
ons as well as in different intergenic regions (Figs. 8 and 9 and
supplemental Figs. S1 and S2). Based on all of this evidence, we
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propose that NusA, unlike a facilitator of hairpin-dependent
termination, is an antagonist of Rho-dependent termination.
This adds one more function to the multitasking abilities of
NusA, in addition to its roles in transcription elongation, anti-
termination, and DNA repair (11). It should be noted that this
model prescribes for the most effective antagonism by NusA in
the vicinity of the nut/rut sites, because EC-bound NusA is
likely to vacate this site with the progress of transcription elon-
gation. However, on the sites where NusA-nut interaction is
very strong, NusA may remain bound to these sites even after
the EC has progressed farther away from the nut site. An alter-
native to the direct competition betweenNusA and Rho for the
overlapping sites on RNA, in the cases where rut and nut sites
do not overlap, it is possible that NusA binding to the nut site
could remodel the nearby rut site RNA structure to block the
entry of Rho.
Two kinds of crystal structures of Rho has been reported to
date.When the primary RNA binding site of Rho was occupied
FIGURE 10. Rho-NusA competition at the leader region of the rho operon. A, schematic showing the organization and the relevant sequences of the rho
operon.Oligonucleotides RS323, RS1116, andRS1142 (also see Table 1)were used to amplify theDNA template, used in transcription assays, from thegenomic
DNA. Untranslated region is shown in italic type, and the underlined portion within this has a high G/C ratio of 3. The boldface GA sequence is the possible
transcription start site, whereas the boldface ATG is the translation start site. B, autoradiogram showing the in vitro transcription assays on the above template
under different conditions. The termination zones are indicated by dashed lines together with the amount of RO products. RNA length markers are shown on
the left of the gel. C, schematic showing the stalled EC in the termination zone using LacI as a roadblock. Lac operator sequence was introduced at the end of
the template using RS1142 having the operator site, and the site is 135 bp downstreamof the translation start site of rho. Competition between Rho andNusA
fragments for the overlapping binding site(s) in the untranslated region is indicated.D and E, autoradiograms showing the distribution of radiolabeled Rho in
different fractions (half of the supernatant (S) orpellet plus the rest of the supernatant, denotedasP) uponchallengeby the indicatedcompetitors. Competitors
were added togetherwith Rho inD and after the addition of Rho in E. Fractions ([2S]/([S] [S P])) of dissociated Rho are indicated below the lanes. S.D. values
(error bars) were obtained from 2–3 experiments. F, left, a schematic depicting the feedback regulation in the rho operon. Right, Western blot to estimate the
amount of in vivo concentrations of Rho in the presence of WT and mutant NusA. The blot for the -subunit of RNAP is used as a loading control.
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by oligonucleotides, the structure was an open ring (37),
whereas when both the primary and secondary RNA binding
sites were occupied by DNA or RNA oligonucleotides, the
structure appeared as a symmetrical hexameric closed ring (38).
Based on these sequential occupations of the primary and sec-
ondary RNA binding sites, the Rho activation steps may be
described by the following equilibria (21),
R  RNA % (R-RNA)OH3 (R-RNA)CH33 Rho translocation
REACTION 1
where R represents Rho.
Initially, Rho attains an open hexamer (OH) conformation
upon recognizing the rut site, following which it undergoes an
irreversible isomerization to form a closed hexameric (CH)
state. As the CH formation is accompanied by the onset of the
ATP hydrolysis, Rho becomes committed for the translocation.
Due to this irreversibility, once Rho is committed for translo-
cation, it is unlikely to be dissociated by any RNA-binding pro-
tein. Here, we observed that NusA could compete out Rho only
when it was added together with it (Figs. 6 and 10), which indi-
cates that the competition occurs at the (R-RNA)OH formation
stage. We propose that the OH formation is the only step sus-
ceptible to the RNA-binding protein competitors, and thereby
the Rho antagonism is likely to occur via this step.
NusA induces transcription elongation pausing (11); it espe-
cially enhances the RNA-hairpin dependent pauses (39). As per
the kinetic couplingmodel of Rho-dependent termination (40),
pausing of ECs should enhance the termination process.Hence,
NusA should function as a stimulator of Rho-dependent termi-
nation at the hairpin-dependent pause sites, which may occur
less frequently in vivo. However, the RNA hairpin-induced
paused/arrested/backtracked ECs are not good substrates for
Rho (41), and therefore, pause enhancement at these sites by
NusA is not likely to stimulate the Rho function.
The antitermination complex that assembles on the AT-
boxes of the rRNA operon consists of NusA, NusB, NusE, and
NusG and primarily protects the transcription of this untrans-
lated operon from Rho-dependent termination (26, 27).
Assembly of these Nus factors and their subsequent interac-
tions with the EC increase the transcription elongation rate,
which is thought to be the major way of overcoming the “Rho
chase” of the EC (42). Here, we show that in the in vitro setup,
the presence of NusA alone is sufficient to prevent the loading
of Rho to the AT-box region, thereby bringing about efficient
antitermination (Fig. 6). In vitro this effect of NusA may be
localized in the vicinity of the nut site, which only delays the
Rho loading onto the rut site. However, under the in vivo con-
ditions, assembly of the Nus factors further enhance the stabil-
ity of their interactions at the AT-box, which helps them to
occupy this site even when the EC has traversed far away to the
downstream regions, possibly through a looped out RNA struc-
ture, further reducing the chances of Rho to load onto the nas-
cent RNA. Hence, we propose that NusA-Rho competition for
the AT-box is an important component of the antitermination
event in addition to the enhanced elongation rate of the EC
induced by the Nus factors. Because NusE (S10), a component
of the antitermination machinery, can interact with NusG
interaction (43), one can also speculate that this interaction
would prevent Rho-NusG interaction, which in turn would
reduce the efficiency of Rho-dependent termination at this
operon.
The genome-wide antagonism of Rho-dependent termina-
tion arose from the observations of the up-regulation of a sig-
nificant number of common genes/operons in the presence of
termination-defective NusA or Rho mutants (Figs. 8 and 9 and
supplemental Figs. S1 and S2). It is possible that this mode of
down-regulation of Rho-dependent termination by NusA in
non-rRNA operons is reminiscent of the antitermination
mechanism described above. A remote possibility could also be
the existence of an rRNA-like antitermination system in some
other operons, which was manifested as the NusA-mediated
inhibition in our experiments.
Bacteriophage P4 protein Psu (44, 45), E. coli Hfq (46), and
YaeO (47, 48) proteins and the most recently discovered spe-
cific RNA sequence, RARE, in Salmonella (28) are the other
inhibitors of the Rho function. They bind directly to Rho and
inhibit its function. Hence, because of the presence of NusA
and all of these other cis and trans factors, a negative control for
Rho is always present in the cell as a default, which is necessary
to prevent unwanted transcription termination.
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